Global Longlife Hospital and Research Ltd

Global Longlife Hospital and Research Ltd

₹ 12.2 -1.69%
24 Jul - close price
About

Incorporated in 2015, Global Longlife Hospital & Research Ltd is in the business of Health Care and Hospitals[1]

Key Points

Business Overview[1]
The company operates a multi-specialty tertiary care hospital in Gujarat, providing infrastructure and clinical support for a broad range of medical and surgical specialties. It follows an open-doctor model, allowing qualified doctors with 3+ years of experience to admit and treat patients at the hospital.

  • Market Cap 12.8 Cr.
  • Current Price 12.2
  • High / Low 26.7 / 9.00
  • Stock P/E
  • Book Value 22.6
  • Dividend Yield 0.00 %
  • ROCE -3.92 %
  • ROE -6.81 %
  • Face Value 10.0

Pros

  • Company is almost debt free.
  • Stock is trading at 0.54 times its book value

Cons

  • Company has low interest coverage ratio.
  • Promoter holding is low: 22.9%
  • Company has a low return on equity of -8.85% over last 3 years.
  • Promoter holding has decreased over last 3 years: -31.4%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2021 Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025 Mar 2026
19.94 12.87 11.80 11.70 12.33 1.18 0.58 0.00 0.00 0.00
13.18 11.61 10.03 9.44 9.62 4.20 4.39 0.35 0.60 0.40
Operating Profit 6.76 1.26 1.77 2.26 2.71 -3.02 -3.81 -0.35 -0.60 -0.40
OPM % 33.90% 9.79% 15.00% 19.32% 21.98% -255.93% -656.90%
0.07 0.16 0.07 0.17 0.02 0.04 5.69 -0.67 0.01 0.00
Interest 0.09 1.31 0.20 0.20 0.41 0.36 0.28 0.00 0.00 0.00
Depreciation 0.58 0.57 0.58 0.59 0.61 0.64 0.48 0.00 0.00 0.00
Profit before tax 6.16 -0.46 1.06 1.64 1.71 -3.98 1.12 -1.02 -0.59 -0.40
Tax % 0.00% -78.26% 29.25% 35.37% 39.77% -19.10% -11.61% 2.94% 123.73% 0.00%
6.17 -0.10 0.76 1.07 1.03 -3.22 1.24 -1.04 -1.32 -0.40
EPS in Rs 8.81 -0.14 0.72 1.02 0.98 -3.07 1.18 -0.99 -1.26 -0.38
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
33.44 33.32 32.70 32.44 23.38 13.46 0.31 0.00
26.61 29.88 27.26 24.14 19.30 13.68 4.45 1.00
Operating Profit 6.83 3.44 5.44 8.30 4.08 -0.22 -4.14 -1.00
OPM % 20.42% 10.32% 16.64% 25.59% 17.45% -1.63% -1,335.48%
0.08 0.03 0.06 0.17 0.24 0.00 5.02 0.01
Interest 2.07 2.41 2.44 1.62 0.45 0.80 0.30 0.00
Depreciation 2.15 2.13 1.31 1.14 1.17 1.25 0.48 0.00
Profit before tax 2.69 -1.07 1.75 5.71 2.70 -2.27 0.10 -0.99
Tax % 49.07% -18.69% -16.57% 37.30% 32.59% -3.52% -100.00% 73.74%
1.36 -0.86 2.05 3.57 1.83 -2.19 0.20 -1.72
EPS in Rs 1.94 -1.23 2.93 5.10 1.74 -2.09 0.19 -1.64
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -100%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 63%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -33%
1 Year: -49%
Return on Equity
10 Years: %
5 Years: -2%
3 Years: -9%
Last Year: -7%

Balance Sheet

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 7.00 7.00 7.00 7.00 10.50 10.50 10.50 10.50
Reserves 5.35 4.49 6.68 9.96 53.79 15.43 16.29 13.25
27.18 23.51 17.04 8.69 9.29 12.74 0.00 0.00
3.77 6.92 6.06 8.33 2.36 3.07 0.06 0.01
Total Liabilities 43.30 41.92 36.78 33.98 75.94 41.74 26.85 23.76
20.17 18.72 17.46 16.71 16.52 17.27 0.00 0.00
CWIP 0.00 0.00 0.00 0.00 1.03 0.00 0.00 0.00
Investments 0.10 0.10 0.47 0.10 0.10 0.03 0.03 0.00
23.03 23.10 18.85 17.17 58.29 24.44 26.82 23.76
Total Assets 43.30 41.92 36.78 33.98 75.94 41.74 26.85 23.76

Cash Flows

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
5.40 3.90 6.88 9.42 -40.42 -5.07 12.32 -4.51
-0.33 -0.04 0.02 0.01 -1.90 -0.82 21.80 0.04
-4.77 -3.05 -7.22 -9.66 45.70 2.67 -13.01 0.00
Net Cash Flow 0.31 0.81 -0.33 -0.22 3.38 -3.22 21.11 -4.47
Free Cash Flow 5.00 3.79 6.84 8.96 -42.42 -6.10 33.42 -4.51
CFO/OP 79% 113% 126% 105% -960% 2,259% -304% 401%

Ratios

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 94.85 68.68 87.51 100.25 151.43 52.88 376.77
Inventory Days 169.49 157.97 34.46 88.98 69.12 131.64 0.00
Days Payable 229.91 391.69 138.68 432.74 110.43 765.90
Cash Conversion Cycle 34.44 -165.03 -16.71 -243.52 110.13 -581.38 376.77
Working Capital Days 19.21 12.16 7.14 -29.70 344.86 -238.36 1,283.39
ROCE % 3.81% 12.75% 26.22% 6.35% -2.51% -13.69% -3.92%

Insights

In beta
Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
NABH Accreditation Status
Binary (1=Accredited)

Log in to view insights

Please log in to see hidden values.

Login
Total Employees
Number
Total Bed Capacity
Beds
Sale of Products Share of Revenue
% of Revenue from Operations
Solar Power Plant Capacity
KW (DC)

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

2 Recently
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
54.29% 54.29% 54.29% 54.29% 54.29% 54.29% 54.29% 54.90% 55.10% 35.44% 22.88% 22.88%
45.72% 45.71% 45.71% 45.72% 45.73% 45.72% 45.70% 45.10% 44.91% 64.56% 77.11% 77.12%
No. of Shareholders 8809359471,0109749899389179159851,1491,133

Documents